Clinical Trial Update: Bias Source of Signal in SCOUT DS

View source ↗

Summary

Clinical trial update indicates termination of the SCOUT DS study in Type 2 diabetes mellitus, with notes on bias sources of the signal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: VeraLight, Inc. | Conditions: Type 2 Diabetes | Status: TERMINATED